Baran Chemical & Pharmaceutical Company focuses on active pharmaceutical ingredients and specialty medicines, guided by science and responsibility.
According to the company’s published history, Baran was founded in 1995/96 (1374 SH). Redevelopment for oral oncology active ingredients began in 2011/12 (1390 SH), followed by investment in finished dosage manufacturing.
This journey centres on production, research and quality capabilities. Further company information and photography will complete this story.
Attention to quality throughout development and production.
Learning and developing specialist capabilities.
Clear communication with patients and professional partners.
Baran focuses on developing and producing active ingredients and formulations for hazardous and oral oncology medicines. Its published portfolio includes both APIs and finished medicines, serving different audiences and information needs.
This website separates technical ingredient information for professional partners from medicine information and educational resources for patients.
According to the company’s history, capecitabine and imatinib API production began in 1394 SH, followed by additional ingredients. Investment in an oncology tablet and capsule line started in 1398 SH, with commissioning reported in 1402 SH.
Baran’s stated mission is to develop and supply medicines through specialist expertise, technology and attention to quality in support of patient health. Building scientific capabilities and international market participation also form part of its published outlook.
Social and professional responsibility, respect for people and staff, continuous learning and improvement are among the company’s published values. Patient guides, access enquiries and safety reporting support clearer communication through the new website.